BAY865321 HD 8mg AMD - Ph 3
Research payments
$5,485,678
Through program year 2021, $5,485,678 in research payments was reported against BAY865321 HD 8mg AMD - Ph 3, across 353 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $5,397,695 | 330 |
| 2020 | Research | $87,983 | 23 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Calvin Mein San Antonio, TX Named on 94 payments
- Steve Charles Germantown, TN Named on 19 payments
- Nikolas London San Diego, CA Named on 17 payments
- Scott McClintic Salem, OR Named on 15 payments
- James Dooner Austin, TX Named on 15 payments
- Patrick Williams Arlington, TX Named on 13 payments
- Ramin Sarrafizadeh Colorado Springs, CO Named on 12 payments
- Jeffrey Heier Boston, MA Named on 9 payments
- Charles Wykoff Houston, TX Named on 9 payments
- Kenneth Graham Great Neck, NY Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.